tizanidine hydrochloride
- Product NDC
- 72888-161
- 11-digit product format
- 728880161
- Labeler code
- 72888
- Product ID
- 72888-161_3f9bf106-484a-1c3c-e063-6394a90ac8a6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tizanidine hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Advagen Pharma Limited
- Application
- ANDA213798
- Marketing category
- ANDA
- Marketing start
- 2025-08-28
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 8 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- tizanidine hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TIZANIDINE HYDROCHLORIDE | 8 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | B53E3NMY5C |
| Rxcui | 485484, 485485, 485486, 2723708 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72888-161-15 | tizanidine hydrochloride | 150 in 1 BOTTLE | CAPSULE | 150 | | 5 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 72888-161-15 | 72888016115 | 150 CAPSULE in 1 BOTTLE (72888-161-15) | 150 capsule | 2025-08-28 | No | No | Current |